For part 2 of this posting on the new Infectious Diseases Society of America (IDSA) MRSA Guidelines I would like to comment on some of the Executive Summary points made about MRSA bone and joint infections and also vancomycin dosing …
Read more →
Warren S. Joseph DPM FIDSA
Page 4
After an extended, deliberative writing and review process the brand new Infectious Diseases Society of America clinical practice guidelines on the treatment of MRSA have finally been published (full text at http://cid.oxfordjournals.org/content/early/2011/01/04/cid.ciq146.full.pdf+html). I really feel that this document is a …
Read more →One of this blog’s readers, Dr. McLeod, asked the following: My question is: Does one need to prescribe antibiotics after I+Ding an abscess? I use to work at a county hospital in Oakland, California where there was a high MRSA …
Read more →Well, the comments have come in and this is what I received – my comments, if any, are in italics: – Interesting question as I just received a memo from the dental school at the University asking my preferences regarding …
Read more →With this blog entry I am going to try something a bit different. I know that there is a good readership of my posts but, to date, I have been somewhat disappointed in the number of comments and interactions I …
Read more →I received this question from a reader: In suspected osteomyelitis do you stop antibiotics prior to obtaining a bone culture? For how long? This comment came in under my entry on the VULCAN trial but I actually covered the question …
Read more →Well, as I expected and predicted in my previous post, the FDA did not waste much time approving ceftaroline (trade name – Teflaro) for complicated skin and skin structure infections (cSSSI). http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm231594.htm (thanks to Lee Rogers, DPM for forwarding me …
Read more →For a number of years it was widely felt that the first of the new so-called “5th Generation”, or anti-MRSA cephalosporins would be ceftobiprole. This drug, a joint venture by the Swiss company Basilea and Johnson & Johnson had come …
Read more →Instead of a formal literature review, I just wanted to post a quick clinical comment on something that came up with a patient I saw on consultation in the hospital about 2 weeks ago. This 91 y/o female nursing home …
Read more →It is a rare study I read that makes me want to literally stop everything else I am doing and write a blog post about it. It is a dreary, gray Sunday morning and I was just catching up on …
Read more →